Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microfluidic Application Centre Appoints Gillian Davis to Strategic Commercial Role

Published: Monday, September 17, 2007
Last Updated: Monday, September 17, 2007
Bookmark and Share
Dr. Gillian will be instrumental in securing new business opportunities and managing customer relations at Dolomite microfluidic capabilities and services.

Dolomite has appointed Dr Gillian Davis to the position of Commercial Director. In this strategic role, Gillian will be instrumental in securing new business opportunities and managing customer relations for Dolomite’s microfluidic capabilities and services.

‘This is an exciting development for us,’ said Mark Gilligan, Managing Director of Dolomite, ‘and reflects the increasing level of interest we are experiencing around the world from customers interested in working with us to bring their microfluidic concepts to market.’

‘I am delighted to welcome Gillian on board, she brings to the company not only a strong background in business development, but also extensive experience of working at the cutting edge of a diverse range of technical disciplines, including materials processing, liquid crystal displays and fibre optic communications. Having people on board with a broad technical background is particularly important to a company, such as Dolomite, which offers a service with an extremely wide application base, including environmental monitoring, clinical diagnostics, drug discovery, nuclear fuels reprocessing and forensic science.’

Dolomite’s key strength lies in being able to offer a complete service to customers from problem conceptualisation and feasibility testing through to full instrument design and development.

The Company says, Gillian’s appointment is just the beginning of Dolomite’s efforts to meet the demand from customers for a partner they can work with to bring their concepts for microfluidic products to market.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Dolomite and Lab on a Chip Launch Video Competition to Win $2,500 of Microfluidic Equipment
Microfluidics specialist Dolomite has teamed up with Lab on a Chip and the Chemical and Biological Microsystems Society to create the first ever MicroTAS Video Competition.
Thursday, October 08, 2015
Sales of Dolomite’s Micro Droplet Systems Reach Record High
Dolomite Microfluidics, the world leader in innovative microfluidic products, has seen significant growth in the sale of its Micro Droplet Systems, particularly for cell encapsulation applications.
Tuesday, June 02, 2015
Enter the Dolomite and Lab on a Chip Productizing Science® Competition 2015 Now!
Don’t miss the chance to drive microfluidics innovation forwards.
Thursday, April 23, 2015
Dolomite and Lab on a Chip Launch Productizing Science® Competition 2015
Competition offers the opportunity to take advantage of Dolomite’s invaluable commercial expertise and in-depth understanding of the international microfluidics market.
Wednesday, October 08, 2014
Dolomite Announces Exclusive Agreement with Fluika
Agreement for the sale of compact microfluidic pressure and vacuum pumps for pneumatic control systems in microfluidics, chemistry and mechatronics.
Tuesday, August 05, 2014
Dolomite Announces 2013 Productizing Science® Competition Winner
Fully automated DNA lab-on-a-chip microfluidic system wins Dolomite’s competition.
Tuesday, June 10, 2014
Dolomite Microfluidics, Sphere Fluidics Partner
Agreement will see companies deliver world leading droplet based technology.
Thursday, May 01, 2014
R&D Consortium to Develop Optical Sorting of Stem Cells
Dolomite is collaborating with European technology leaders over a two year publicly funded consortium.
Tuesday, December 17, 2013
Epigem and Dolomite Join Forces
Both Companies announces collaboration in the design and manufacture of microfluidic devices.
Wednesday, March 13, 2013
Dolomite Celebrates a Successful 2012
Microfluidics company Dolomite has reported an exceptional 20% year-on-year growth in 2012.
Tuesday, February 12, 2013
Dolomite Announces Microdroplet IP License Arrangements with JST
Dolomite offers a wide range of Droplet-forming devices.
Friday, August 24, 2012
Dolomite’s Launches Productizing Science™ Competition
New competition offering the chance to productize scientific discoveries.
Monday, June 18, 2012
Dolomite Joins Forces with LioniX B.V.
Companies join forces in the areas of designing, developing and fabricating microfluidic devices and systems.
Thursday, May 03, 2012
Dolomite and GigaGen Collaborate to Develop Novel Droplet Merging Technology
Development of a novel Droplet Merger Chip for massively parallel single cell genetic analysis.
Friday, February 17, 2012
Microfluidics Specialist Dolomite Signs Collaboration Agreement with Sphere Fluidics
Sphere Fluidics offers extensive expertise in miniaturized Discovery Systems and Services based on microfluidics and picodroplets.
Wednesday, May 11, 2011
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!